Hostname: page-component-cd9895bd7-hc48f Total loading time: 0 Render date: 2024-12-22T16:47:10.640Z Has data issue: false hasContentIssue false
  • English
  • Français

Anticonvulsant Medication in a Mental Handicap Hospital: 1972–1982

Published online by Cambridge University Press:  02 January 2018

L. C. Sheppard ,
B. R. Ballinger  and
G. W. Fenton
L. C. Sheppard
Affiliation:
Dundee Psychiatric Service
B. R. Ballinger
Affiliation:
Dundee Psychiatric Service
G. W. Fenton*
Affiliation:
University of Dundee
*
∗University of Dundee, Ninewells Hospital, Dundee DD1 9SY
Get access Rights & Permissions [Opens in a new window]

Abstract

The prescription sheets for all patients in a mental handicap hospital on one day in 1972 and on the same date in 1982 were examined to identify trends in anticonvulsant medication over a 10-year period. There was a reduction in size of the hospital population associated with fewer very young and milder handicapped persons. Prescription of anticonvulsants fell slightly during the decade under study with a dramatic fall in the use of phenobarbitone, and a parallel increase in the prescription of carbamazepine. Other changes included the use of sodium valproate in a significant minority of patients and the occasional use of clonazepam in 1982, while phenytoin remained a first-rank anticonvulsant throughout the period under review. The proportions of patients on polytherapy did not change over the 10-year period, though the contribution of phenobarbitone to the combined drug regimes was significantly reduced.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 150 , Issue 4 , April 1987 , pp. 513 - 517
Copyright
Copyright © 1987 The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ballenger, J. C. & Post, R. M. (1980) Carbamazepine (Tegretol) in manic-depressive illness: a new treatment. American Journal of Psychiatry, 137, 782–790.Google ScholarPubMed
Breuning, S. E., Davis, V. J., Matson, J. L. & Ferguson, D. G. (1982) Effects of thioridazine and withdrawal dyskinesias on workshop performance of mentally retarded young adults. American Journal of Psychiatry, 139, 1447–1454.Google ScholarPubMed
Browne, T. R. (1976) Clonazepam - a review of a new anticonvulsant drug. Archives of Neurology, 33, 326–332.CrossRefGoogle ScholarPubMed
Corbett, J. (1981) Epilepsy and mental retardation. In Epilepsy and Psychiatry (eds E. R. Reynolds & M. R. Trimble). Edinburgh: Churchill Livingstone.Google Scholar
Dalby, M. A. (1975) Behavioural effects of carbamazepine. In Advances in Neurology (eds. J. K. Penry & D. D. Daly). New York: Raven Press.Google Scholar
Dodrill, C. B. & Troupin, A. S. (1977) Psychotropic effects of carbamazepine in epilepsy: a double blind comparison with phenytoin. Neurology, 27, 1023–1028.CrossRefGoogle ScholarPubMed
Driefuss, F. E. (1983) Sodium Valproate: a reappraisal. In Recent Advances in Epilepsy (eds T. A. Pedley & B. S. Meldrum). London: Churchill Livingstone.Google Scholar
Gowdey, C. W., Coleman, L. M. & Crawford, E. M. H. (1984) Survey of anticonvulsant and neuroleptic drug use on a residential mental retardation center in Ontario. In Perspectives and Progress in Mental Retardation Vol. II- Biomedical Aspects (ed. J. M. Berg). Baltimore: University Park Press.Google Scholar
Heistad, G. T., Zimmermann, R. L. & Doebler, M. I. (1982) Long term usefulness of thioridazine for institutionalised mentally retarded patients. American Journal of Mental Deficiency, 87, 243–251.Google Scholar
Hirtz, D. G. & Nelson, K. B. (1985) Cognitive effects of anticonvulsant drugs. In Recent Advances in Epilepsy (eds T. A. Pedley & B. S. Meldrum). Edinburgh: Churchill Livingstone.Google Scholar
Hughes, P. S. (1977) Survey of medication in a subnormality hospital. British Journal of Mental Subnormality, 13, 88–94.CrossRefGoogle Scholar
James, D. H. (1983) Monitoring drugs in hospitals for the mentally handicapped. British Journal of Psychiatry, 142, 163–165.CrossRefGoogle ScholarPubMed
Kirman, B. (1975) Drug therapy in mental handicap. British Journal of Psychiatry, 127, 545–549.CrossRefGoogle ScholarPubMed
Reid, A. H. (1982) Psychiatry of Mental Handicap. Oxford: Blackwell.Google Scholar
Reid, A. H., Naylor, G. J. & Kay, D. S. G. (1981) A double blind placebo controlled crossover trial of carbamazepine in overactive severely mentally handicapped patients. Psychological Medicine, 11, 109–113.CrossRefGoogle ScholarPubMed
Reynolds, E. H. (1975) Chronic antiepileptic toxicity: a review. Epilepsia, 16, 319–332.CrossRefGoogle ScholarPubMed
Reynolds, E. H. & Travers, R. D. (1974) Serum anticonvulsant concentrations in epileptic patients with mental symptoms. British Journal of Psychiatry, 124, 440–445.CrossRefGoogle ScholarPubMed
Schmidt, D. (1985) Benzodiazepines - an update. In Recent Advances in Epilepsy 2 (eds T. A. Pedley & B. S. Meldrum). Edinburgh: Churchill Livingstone.Google Scholar
Snaith, R. P., James, F. E. & Winokur, B. (1979) The drug treatment of mental illness and epilepsy in the mentally handicapped patient. In Psychiatric Illness and Mental Handicap (eds F. E. James & R. P. Snaith). London: Gaskell.Google Scholar
Spencer, D. A. (1974) A survey of the medication in a hospital for the mentally handicapped. British Journal of Psychiatry, 124, 507–508.CrossRefGoogle Scholar
Stores, G. (1975) Behavioural effects of anti-epileptic drugs. Developmental Medicine and Child Neurology, 17, 647–658.CrossRefGoogle ScholarPubMed
Thompson, P. J. & Trimble, M. R. (1982) Anticonvulsant drugs and cognitive functions. Epilepsia, 23, 531–534.CrossRefGoogle ScholarPubMed
Thompson, P., Muppert, F. A. & Trimble, M. (1981) Phenytoin and cognitive function: effects on normal volunteers and implications for epilepsy. British Journal of Clinical Psychology, 20, 155–162.CrossRefGoogle ScholarPubMed
Trimble, M. & Corbett, J. A. (1980) Behaviour and cognitive disturbances in epileptic children. Irish Medical Journal Supplement, 73, 21–28.Google Scholar
Trimble, M. R. & Reynolds, E. H. (1976) Anticonvulsant drugs and mental symptoms: a review. Psychological Medicine, 6, 169–178.CrossRefGoogle ScholarPubMed
Troupin, A. S. (1983) Carbamazepine re-examined. In Recent Advances in Epilepsy 1 (eds T. A. Pedley & B. S. Meldrum). London: Churchill Livingstone.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.